BioAge Labs Ratios (2023-2026) | BIOA

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) -219.02%-478.57%-496.30%-504.84%-374.06%
EBT Margin (Quarter) -895.04%-893.53%-979.99%-835.71%-798.92%
EBIT Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%-915.40%
EBITDA Margin (Quarter) -889.66%-896.14%-978.97%-842.76%-810.17%
Operating Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%-915.40%
Net Margin (Quarter) -895.04%-893.53%-979.99%-835.71%-798.92%
FCF Margin (Quarter) -1,225.98%-834.49%-782.18%-921.47%-868.40%
Efficiency
Assets Average (Quarter) 347.81M351.04M332.99M313.62M299.99M346.27M
Equity Average (Quarter) -163.27M-179.45M-191.32M58.31M318.44M318.15M303.97M286.12M274.76M325.59M
Invested Capital (Quarter) -153.14M-167.40M-185.51M-197.13M319.75M329.13M319.17M299.78M280.96M274.05M379.62M
Asset Utilization Ratio (Quarter) 0.000.010.020.030.03
Leverage & Solvency
Interest Coverage Ratio (Quarter) -4.11-5.31-10.53-34.47-63.79-79.50-64.49-123.24-155.30-308.95-650.64
Debt to Equity (Quarter) -0.080.030.030.020.020.010.010.00
Debt Ratio (Quarter) 0.550.030.020.020.020.010.010.00
Equity Ratio (Quarter) -6.690.930.900.910.920.910.920.95
Times Interest Earned (Quarter) -4.11-5.31-10.53-34.47-63.79-79.50-64.49-123.24-155.30-308.95-650.64
Valuation
Enterprise Value (Quarter) -24.96M-173.99M-334.50M-354.35M-320.23M-297.01M-285.78M-281.10M-383.19M
Return Ratios
Return on Sales (Quarter) -0.09%-0.09%-0.10%-0.08%-0.08%
Return on Capital Employed (Quarter) -24.43%-25.00%-29.45%-31.03%-33.15%-30.78%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%